These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25152517)

  • 1. Loss of PP2A and PTEN immunoexpression coexists with survivin overexpression in adenomyosis.
    Zhang H; Liu J; Zhao X; Liang B; Wen Z; Li M
    Reprod Biol; 2014 Sep; 14(3):200-5. PubMed ID: 25152517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway.
    Xu XY; Zhang J; Qi YH; Kong M; Liu SA; Hu JJ
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2218-2225. PubMed ID: 29762822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 receptor regulates AKT protein activation loop (Thr308) dephosphorylation through modulation of the PP2A phosphatase in phosphatase and tensin homolog (PTEN)-null T-cell acute lymphoblastic leukemia cells.
    Hales EC; Orr SM; Larson Gedman A; Taub JW; Matherly LH
    J Biol Chem; 2013 Aug; 288(31):22836-48. PubMed ID: 23788636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expressions of Dusp6, Sprouty4, and Sef, negative regulators of FGF2/ERK1/2 signaling, in the endometrium of women with adenomyosis.
    Guo Q; Zhang H; Zhao X; Fu Y; Zhang J; Li M
    Int J Gynecol Pathol; 2014 May; 33(3):288-97. PubMed ID: 24681741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL8 enhances proliferation and growth and reduces apoptosis in endometrial stromal cells in an autocrine manner via a CXCR1-triggered PTEN/AKT signal pathway.
    Li MQ; Luo XZ; Meng YH; Mei J; Zhu XY; Jin LP; Li DJ
    Hum Reprod; 2012 Jul; 27(7):2107-16. PubMed ID: 22563025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid Arthritis Fibroblast-like Synoviocyte Suppression Mediated by PTEN Involves Survivin Gene Silencing.
    Chen D; Liu D; Liu D; He M; Peng A; Xu J; Lin L; Luo F; Chen L; Huang X; Zhuang J; Xu J
    Sci Rep; 2017 Mar; 7(1):367. PubMed ID: 28337018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.
    Chock KL; Allison JM; Shimizu Y; ElShamy WM
    Cancer Res; 2010 Nov; 70(21):8782-91. PubMed ID: 20940403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
    Xue J; Zhang H; Liu W; Liu M; Shi M; Wen Z; Li C
    Reproduction; 2013 Oct; 146(4):397-406. PubMed ID: 23904524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
    Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
    Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursolic acid-induced apoptosis in K562 cells involving upregulation of PTEN gene expression and inactivation of the PI3K/Akt pathway.
    Wu B; Wang X; Chi ZF; Hu R; Zhang R; Yang W; Liu ZG
    Arch Pharm Res; 2012 Mar; 35(3):543-8. PubMed ID: 22477202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Akt Activation During Implantation Window in Infertile Women With Intramural Uterine Fibroids.
    Makker A; Goel MM; Nigam D; Mahdi AA; Das V; Agarwal A; Pandey A; Gautam A
    Reprod Sci; 2018 Aug; 25(8):1243-1253. PubMed ID: 29113583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrantly expressed long noncoding RNAs in the eutopic endometria of patients with uterine adenomyosis.
    Jiang JF; Sun AJ; Xue W; Deng Y; Wang YF
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():32-7. PubMed ID: 26896594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium.
    Hsu AH; Lum MA; Shim KS; Frederick PJ; Morrison CD; Chen B; Lele SM; Sheinin YM; Daikoku T; Dey SK; Leone G; Black AR; Black JD
    Cell Rep; 2018 Jul; 24(3):655-669. PubMed ID: 30021163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of PTEN expression in psoriatic lesions.
    Li Y; Man X; You L; Xiang Q; Li H; Xu B; Chen Z; Zhang X; Lian S
    Int J Dermatol; 2014 Jul; 53(7):855-60. PubMed ID: 24168180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
    Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
    Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of bcl-2, bax and ER in foci of adenomyosis].
    Li B; Wang L; Fan Y; Wang J; Guo D
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):923-7. PubMed ID: 23324193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
    Patel R; Gao M; Ahmad I; Fleming J; Singh LB; Rai TS; McKie AB; Seywright M; Barnetson RJ; Edwards J; Sansom OJ; Leung HY
    J Clin Invest; 2013 Mar; 123(3):1157-75. PubMed ID: 23434594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PP2A activity is controlled by methylation and regulates oncoprotein expression in melanoma cells: a mechanism which participates in growth inhibition induced by chloroethylnitrosourea treatment.
    Guénin S; Schwartz L; Morvan D; Steyaert JM; Poignet A; Madelmont JC; Demidem A
    Int J Oncol; 2008 Jan; 32(1):49-57. PubMed ID: 18097542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.